Single Page | 
Multiple Pages
Home > BizTimes Daily > Archives > May 14, 2008
Germantown manufacturer to expand
Published May 14, 2008 - BizTimes Daily
Cambridge Major Laboratories Inc. today announced a major expansion of its pharmaceutical plant in Germantown.
The company will break ground on June 5 on a new 120,000-square-foot plant next to its headquarters at W130 N10497 Washington Drive.
The expansion will enable the company to engage in large-scale active pharmaceutical ingredient (API) manufacturing.
Cambridge Major Laboratories is a global service-based chemistry outsourcing partner to the pharmaceutical and biotechnology industries, producing pharmaceutical intermediates, APIs and other fine organic chemicals.
The new plant is being designed with multiple manufacturing suites capable of producing multi-ton quantities of API, and is in response to the company's large and growing pipeline of late developmental and commercial APIs.
Completion is scheduled for August 2009.
The expansion will enable the company to create 50 to 75 new jobs. Currently, about 100 people are employed at the Germantown headquarters, which is functioning at capacity.
The facility will house several vessels for hydrogenation and cryogenic reactions, giving the site maximum flexibility and utility. The facility has been designed to accommodate additional manufacturing suites up to 4000 gallon scale, and these will be built out as the needs arise.
"It is vitally important for us to extend our service offerings as we have numerous projects in Phase III clinical trials, and our desire is to retain the technology and customers for the initial several years of commercial manufacturing. Since there will be no tech transfers or re-validations of processes and suppliers, delivery of API should be guaranteed along with significant time and cost savings. This will also free additional capacity in our existing developmental plants, in particular where cryogenic reactions and hydrogenations are part of the process," said Michael Major.
As part of Cambridge Major's growth strategy announced in 2007, it is investing internally and through acquisition to continue to drive the 30 percent annual growth rate the company has experienced since its inception in 1999.
